Harbor:Sepsis antibiotics: Difference between revisions

Line 32: Line 32:
**'''[[Meropenam]] '''1g IV  + '''[[Levofloxacin]] '''750mg IV (Levofloxacin for synergy)
**'''[[Meropenam]] '''1g IV  + '''[[Levofloxacin]] '''750mg IV (Levofloxacin for synergy)
*'''Aspiration risk:'''  
*'''Aspiration risk:'''  
**Add [[Clindamycin]] 600 mg or [[Metronidazole]] 500 mg
**Add [[Clindamycin]] 600 mg or [[Metronidazole]] 500 mg (unless already on Meropenem)


===Healthcare Associated [[pneumonia]] (HCAP) + Hospital Associated [[pneumonia]] (HAP)===
===Healthcare Associated [[pneumonia]] (HCAP) + Hospital Associated [[pneumonia]] (HAP)===

Revision as of 23:10, 21 February 2019

Unknown Source[1]

Pneumonia

Community Acquired Pneumonia (CAP)

MCC by S. pneumoniae. In young must cover for mycoplasma and other atypicals. See Pneumonia (Pathogens)

Treatment based on Pneumonia (Port Score)

Healthcare Associated pneumonia (HCAP) + Hospital Associated pneumonia (HAP)

HAP occurs if patient develops pneumonia 2-3 days after hospitalization. HCAP occus in non-hospitalized patient with extensive healthcare contact.

Abdominal/Pelvic

UTI with Sepsis

Meningitis

  • Immunocompromised (Cirrhosis, EtoH, age > 65, steroids, HIV)

Necrotizing Soft-tissue Infection

Neutropenic Fever

See Also

Harbor:Antibiotics by diagnosis

See also Harbor: Sepsis core measures
Initial Antibiotics in Sepsis (Main)

References

  1. Form v2011.09.15